Legal Injury GuideOzempic, Wegovy & Mounjaro Gastroparesis Lawsuits: A Plain-English Guide
GLP-1 drugs (Ozempic, Wegovy, Mounjaro, Trulicity) face gastroparesis and severe stomach-injury lawsuits. Learn the injury pattern, evidence needed, and claim timeline.
GLP-1 medications — semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound), along with older GLP-1 drugs like Trulicity — have become some of the most widely prescribed medications in the country for diabetes and weight loss. With that scale of use has come a wave of product liability claims alleging the manufacturers knew or should have known about severe gastrointestinal injuries and did not adequately warn patients and doctors.
This is general educational information about an evolving area of litigation, not legal advice, and it does not predict the outcome of any pending case.
---
What these lawsuits actually allege
The core claims are narrower than "I had nausea on Ozempic." Nausea, mild vomiting, and constipation are already disclosed, common side effects. The lawsuits instead focus on a more severe pattern:
- **Gastroparesis** — the stomach muscles slow or stop working normally, delaying digestion for weeks or months, sometimes requiring feeding tubes
- **Severe, prolonged vomiting** leading to dehydration, esophageal damage, or hospitalization
- **Bowel obstruction / ileus** — the intestines partially or fully stop moving contents
- **Failure-to-warn** claims — that the label did not clearly disclose the risk of gastroparesis specifically, as opposed to routine GI side effects
Litigation in this space is largely proceeding as a federal multidistrict litigation (MDL), which consolidates similar claims from around the country before one court for shared pretrial proceedings — it does not merge the cases into one lawsuit or guarantee any particular result.
---
Injury pattern that supports a claim
| Signal | Why it matters |
|---|---|
| Diagnosis of gastroparesis or "delayed gastric emptying" by a doctor | Ties the specific injury to the drug class, not just "felt sick" |
| ER visit or hospitalization for vomiting/dehydration | Shows severity beyond a routine side effect |
| Symptoms that continued or worsened after stopping the medication | Distinguishes lasting injury from temporary adjustment |
| Gastric emptying study, endoscopy, or imaging results | Objective medical evidence, not just self-reported symptoms |
| Timeline showing use of Ozempic/Wegovy/Mounjaro/Trulicity/Rybelsus/Zepbound before symptoms started | Establishes the medication-injury link |
If your experience was limited to typical nausea that resolved with dose adjustment, that alone is unlikely to support a claim — the label already warns about it.
---
Records to start gathering now
- **Pharmacy fill history** — dates, dosages, and which specific drug (brand and generic name matter)
- **Prescribing records** — why it was prescribed (diabetes vs. weight loss can matter for some claims)
- **All GI-related medical visits** after starting the drug — primary care, ER, gastroenterology
- **Diagnostic testing** — gastric emptying scans, endoscopy, imaging, hospital discharge summaries
- **A simple symptom timeline** — when the drug started, when symptoms began, when (if ever) they improved after stopping
Insurance Explanation of Benefits (EOBs) can help reconstruct a timeline even if you don't have every original chart note yet.
---
Common questions people have before calling a lawyer
Does it matter if I'm still taking the medication? Tell any attorney the full truth, including current use. It affects strategy but does not automatically disqualify a claim tied to a past severe episode.
What if my doctor never used the word "gastroparesis"? Ask your doctor directly whether "delayed gastric emptying" or a similar diagnosis applies, or request a referral for a gastric emptying study if symptoms are ongoing. A clear diagnosis materially strengthens a claim; vague symptom descriptions alone are harder to evaluate.
Is this the same as a normal product liability car-part or drug case? The legal theories (failure to warn, design defect, negligence) are similar in structure to other pharmaceutical mass tort cases, but GLP-1 litigation is still developing — case evaluation criteria can change as more bellwether cases and scientific evidence develop.
---
Red flags that usually mean it's worth a free consult
- A formal gastroparesis or delayed-gastric-emptying diagnosis after GLP-1 use
- Hospitalization or ER visits for vomiting, dehydration, or bowel obstruction
- Symptoms lasting weeks to months, especially after stopping the drug
- A feeding tube, IV fluids, or significant unplanned weight loss from the injury itself
- Ongoing digestive impairment affecting daily life or work
A short intake call with a firm handling this litigation is normally free and does not commit you to anything. Bring your medication and symptom timeline — it is the single most useful document you can hand over.
---
Bottom line
GLP-1 gastroparesis litigation is about a specific, documented severe injury pattern — not routine side effects. If your experience matches the injury pattern above and you have (or can get) medical documentation connecting it to the drug, gathering your records now is the highest-value first step, whether or not you ultimately pursue a claim.
Frequently Asked Questions
What injury do GLP-1 lawsuits actually cover?
Most claims center on gastroparesis (delayed stomach emptying / "stomach paralysis"), severe and prolonged vomiting, bowel obstruction, and related hospitalizations — not general side effects like mild nausea, which is a listed, disclosed risk on the label.
Do I need a lawsuit already filed to talk to a lawyer?
No. Most firms evaluate cases before any suit is filed and often work on contingency, meaning no upfront fee. Gathering your records early protects your options either way.
For informational purposes only. Not legal advice. Consult a licensed attorney.